Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Sedation in OSA
NCT01733043Phase 3Withdrawn
- Sponsor
- Duke University
- Start
- Mar 2015
- Primary completion
- May 2015
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in obstructive sleep apnea (OSA) comparing Dexmedetomidine infusion with Placebo (2 arms). Primary endpoint: Apnea Hypopnea Index. Planned start Mar 2015; status: withdrawn.
02
Drugs
dexmedetomidine
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT01733043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01733043.